Abstract
Acute influenza virus infection causes accumulation of reactive oxygen species (ROS) in target organs, initiating the processes of free radical lipid peroxidation (LPO) (Peterhanse 1997, Buffinton et al. 1992, Chetverikova et al. 1996). Rimantadine (Rim), (α-methyl-l-adamantil-methylamin hydrochlorid), a universal inhibitor of type A virus, is widely used in chemotherapeutic treatment and prevention of influenza. Rim interacts with the M-2 protein of the virus, inhibits its replication and blocks the formation of some replicative components of the influenza virus (Belshe et al. 1988, Zhiravetskii 1986). At present, it is not clear how Rim can affect the processes of LPO and drug metabolizing enzyme systems (DMES) during experimental influenza virus infection.KeywordsInfluenza VirusInfluenza Virus InfectionMonooxygenase ActivityAniline HydroxylaseDrug Metabolize Enzyme SystemThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
